Opioid Induced Side Effects Treatment Market - Global Outlook and Forecast 2022-2028
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group.
This report contains market size and forecasts of Opioid Induced Side Effects Treatment in Global, including the following market information:
Global Opioid Induced Side Effects Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Opioid Induced Side Effects Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Risperidone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioid Induced Side Effects Treatment include Shionogi, Cubist Pharmaceuticals, SLA Pharma, AstraZeneca, AIKO Biotechnology and Progenics Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Induced Side Effects Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Induced Side Effects Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Opioid Induced Side Effects Treatment Market Segment Percentages, by Type, 2021 (%)
Global Opioid Induced Side Effects Treatment Market Segment Percentages, by Application, 2021 (%)
Global Opioid Induced Side Effects Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Opioid Induced Side Effects Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Opioid Induced Side Effects Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Opioid Induced Side Effects Treatment in Global, including the following market information:
Global Opioid Induced Side Effects Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Opioid Induced Side Effects Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Risperidone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Opioid Induced Side Effects Treatment include Shionogi, Cubist Pharmaceuticals, SLA Pharma, AstraZeneca, AIKO Biotechnology and Progenics Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Induced Side Effects Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Opioid Induced Side Effects Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Opioid Induced Side Effects Treatment Market Segment Percentages, by Type, 2021 (%)
- Risperidone
- Methylphenidate
- Cetirizine
- Other
Global Opioid Induced Side Effects Treatment Market Segment Percentages, by Application, 2021 (%)
- Drug Overdose Treatment
- Pain Treatment
- Other
Global Opioid Induced Side Effects Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Opioid Induced Side Effects Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Opioid Induced Side Effects Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Shionogi
- Cubist Pharmaceuticals
- SLA Pharma
- AstraZeneca
- AIKO Biotechnology
- Progenics Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Opioid Induced Side Effects Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Induced Side Effects Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OPIOID INDUCED SIDE EFFECTS TREATMENT OVERALL MARKET SIZE
2.1 Global Opioid Induced Side Effects Treatment Market Size: 2021 VS 2028
2.2 Global Opioid Induced Side Effects Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Opioid Induced Side Effects Treatment Players in Global Market
3.2 Top Global Opioid Induced Side Effects Treatment Companies Ranked by Revenue
3.3 Global Opioid Induced Side Effects Treatment Revenue by Companies
3.4 Top 3 and Top 5 Opioid Induced Side Effects Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Opioid Induced Side Effects Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opioid Induced Side Effects Treatment Players in Global Market
3.6.1 List of Global Tier 1 Opioid Induced Side Effects Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Opioid Induced Side Effects Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Opioid Induced Side Effects Treatment Market Size Markets, 2021 & 2028
4.1.2 Risperidone
4.1.3 Methylphenidate
4.1.4 Cetirizine
4.1.5 Other
4.2 By Type - Global Opioid Induced Side Effects Treatment Revenue & Forecasts
4.2.1 By Type - Global Opioid Induced Side Effects Treatment Revenue, 2017-2022
4.2.2 By Type - Global Opioid Induced Side Effects Treatment Revenue, 2023-2028
4.2.3 By Type - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Opioid Induced Side Effects Treatment Market Size, 2021 & 2028
5.1.2 Drug Overdose Treatment
5.1.3 Pain Treatment
5.1.4 Other
5.2 By Application - Global Opioid Induced Side Effects Treatment Revenue & Forecasts
5.2.1 By Application - Global Opioid Induced Side Effects Treatment Revenue, 2017-2022
5.2.2 By Application - Global Opioid Induced Side Effects Treatment Revenue, 2023-2028
5.2.3 By Application - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Opioid Induced Side Effects Treatment Market Size, 2021 & 2028
6.2 By Region - Global Opioid Induced Side Effects Treatment Revenue & Forecasts
6.2.1 By Region - Global Opioid Induced Side Effects Treatment Revenue, 2017-2022
6.2.2 By Region - Global Opioid Induced Side Effects Treatment Revenue, 2023-2028
6.2.3 By Region - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.3.2 US Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.3.3 Canada Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.3.4 Mexico Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.4.2 Germany Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.3 France Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.4 U.K. Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.5 Italy Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.6 Russia Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.8 Benelux Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.5.2 China Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5.3 Japan Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5.4 South Korea Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5.6 India Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.6.2 Brazil Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.6.3 Argentina Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.7.2 Turkey Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.7.3 Israel Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.7.5 UAE Opioid Induced Side Effects Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Shionogi
7.1.1 Shionogi Corporate Summary
7.1.2 Shionogi Business Overview
7.1.3 Shionogi Opioid Induced Side Effects Treatment Major Product Offerings
7.1.4 Shionogi Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.1.5 Shionogi Key News
7.2 Cubist Pharmaceuticals
7.2.1 Cubist Pharmaceuticals Corporate Summary
7.2.2 Cubist Pharmaceuticals Business Overview
7.2.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Major Product Offerings
7.2.4 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.2.5 Cubist Pharmaceuticals Key News
7.3 SLA Pharma
7.3.1 SLA Pharma Corporate Summary
7.3.2 SLA Pharma Business Overview
7.3.3 SLA Pharma Opioid Induced Side Effects Treatment Major Product Offerings
7.3.4 SLA Pharma Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.3.5 SLA Pharma Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Opioid Induced Side Effects Treatment Major Product Offerings
7.4.4 AstraZeneca Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.4.5 AstraZeneca Key News
7.5 AIKO Biotechnology
7.5.1 AIKO Biotechnology Corporate Summary
7.5.2 AIKO Biotechnology Business Overview
7.5.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Major Product Offerings
7.5.4 AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.5.5 AIKO Biotechnology Key News
7.6 Progenics Pharmaceuticals
7.6.1 Progenics Pharmaceuticals Corporate Summary
7.6.2 Progenics Pharmaceuticals Business Overview
7.6.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Major Product Offerings
7.6.4 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.6.5 Progenics Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Opioid Induced Side Effects Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Opioid Induced Side Effects Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL OPIOID INDUCED SIDE EFFECTS TREATMENT OVERALL MARKET SIZE
2.1 Global Opioid Induced Side Effects Treatment Market Size: 2021 VS 2028
2.2 Global Opioid Induced Side Effects Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Opioid Induced Side Effects Treatment Players in Global Market
3.2 Top Global Opioid Induced Side Effects Treatment Companies Ranked by Revenue
3.3 Global Opioid Induced Side Effects Treatment Revenue by Companies
3.4 Top 3 and Top 5 Opioid Induced Side Effects Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Opioid Induced Side Effects Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opioid Induced Side Effects Treatment Players in Global Market
3.6.1 List of Global Tier 1 Opioid Induced Side Effects Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Opioid Induced Side Effects Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Opioid Induced Side Effects Treatment Market Size Markets, 2021 & 2028
4.1.2 Risperidone
4.1.3 Methylphenidate
4.1.4 Cetirizine
4.1.5 Other
4.2 By Type - Global Opioid Induced Side Effects Treatment Revenue & Forecasts
4.2.1 By Type - Global Opioid Induced Side Effects Treatment Revenue, 2017-2022
4.2.2 By Type - Global Opioid Induced Side Effects Treatment Revenue, 2023-2028
4.2.3 By Type - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Opioid Induced Side Effects Treatment Market Size, 2021 & 2028
5.1.2 Drug Overdose Treatment
5.1.3 Pain Treatment
5.1.4 Other
5.2 By Application - Global Opioid Induced Side Effects Treatment Revenue & Forecasts
5.2.1 By Application - Global Opioid Induced Side Effects Treatment Revenue, 2017-2022
5.2.2 By Application - Global Opioid Induced Side Effects Treatment Revenue, 2023-2028
5.2.3 By Application - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Opioid Induced Side Effects Treatment Market Size, 2021 & 2028
6.2 By Region - Global Opioid Induced Side Effects Treatment Revenue & Forecasts
6.2.1 By Region - Global Opioid Induced Side Effects Treatment Revenue, 2017-2022
6.2.2 By Region - Global Opioid Induced Side Effects Treatment Revenue, 2023-2028
6.2.3 By Region - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.3.2 US Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.3.3 Canada Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.3.4 Mexico Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.4.2 Germany Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.3 France Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.4 U.K. Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.5 Italy Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.6 Russia Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.4.8 Benelux Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.5.2 China Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5.3 Japan Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5.4 South Korea Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.5.6 India Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.6.2 Brazil Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.6.3 Argentina Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Opioid Induced Side Effects Treatment Revenue, 2017-2028
6.7.2 Turkey Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.7.3 Israel Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Opioid Induced Side Effects Treatment Market Size, 2017-2028
6.7.5 UAE Opioid Induced Side Effects Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Shionogi
7.1.1 Shionogi Corporate Summary
7.1.2 Shionogi Business Overview
7.1.3 Shionogi Opioid Induced Side Effects Treatment Major Product Offerings
7.1.4 Shionogi Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.1.5 Shionogi Key News
7.2 Cubist Pharmaceuticals
7.2.1 Cubist Pharmaceuticals Corporate Summary
7.2.2 Cubist Pharmaceuticals Business Overview
7.2.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Major Product Offerings
7.2.4 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.2.5 Cubist Pharmaceuticals Key News
7.3 SLA Pharma
7.3.1 SLA Pharma Corporate Summary
7.3.2 SLA Pharma Business Overview
7.3.3 SLA Pharma Opioid Induced Side Effects Treatment Major Product Offerings
7.3.4 SLA Pharma Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.3.5 SLA Pharma Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Opioid Induced Side Effects Treatment Major Product Offerings
7.4.4 AstraZeneca Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.4.5 AstraZeneca Key News
7.5 AIKO Biotechnology
7.5.1 AIKO Biotechnology Corporate Summary
7.5.2 AIKO Biotechnology Business Overview
7.5.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Major Product Offerings
7.5.4 AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.5.5 AIKO Biotechnology Key News
7.6 Progenics Pharmaceuticals
7.6.1 Progenics Pharmaceuticals Corporate Summary
7.6.2 Progenics Pharmaceuticals Business Overview
7.6.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Major Product Offerings
7.6.4 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue in Global Market (2017-2022)
7.6.5 Progenics Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Opioid Induced Side Effects Treatment Market Opportunities & Trends in Global Market
Table 2. Opioid Induced Side Effects Treatment Market Drivers in Global Market
Table 3. Opioid Induced Side Effects Treatment Market Restraints in Global Market
Table 4. Key Players of Opioid Induced Side Effects Treatment in Global Market
Table 5. Top Opioid Induced Side Effects Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Opioid Induced Side Effects Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Opioid Induced Side Effects Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Opioid Induced Side Effects Treatment Product Type
Table 9. List of Global Tier 1 Opioid Induced Side Effects Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Induced Side Effects Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Opioid Induced Side Effects Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Opioid Induced Side Effects Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Opioid Induced Side Effects Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Opioid Induced Side Effects Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Opioid Induced Side Effects Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Opioid Induced Side Effects Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Shionogi Corporate Summary
Table 31. Shionogi Opioid Induced Side Effects Treatment Product Offerings
Table 32. Shionogi Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Cubist Pharmaceuticals Corporate Summary
Table 34. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Offerings
Table 35. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 36. SLA Pharma Corporate Summary
Table 37. SLA Pharma Opioid Induced Side Effects Treatment Product Offerings
Table 38. SLA Pharma Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Opioid Induced Side Effects Treatment Product Offerings
Table 41. AstraZeneca Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 42. AIKO Biotechnology Corporate Summary
Table 43. AIKO Biotechnology Opioid Induced Side Effects Treatment Product Offerings
Table 44. AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Progenics Pharmaceuticals Corporate Summary
Table 46. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Offerings
Table 47. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 1. Opioid Induced Side Effects Treatment Market Opportunities & Trends in Global Market
Table 2. Opioid Induced Side Effects Treatment Market Drivers in Global Market
Table 3. Opioid Induced Side Effects Treatment Market Restraints in Global Market
Table 4. Key Players of Opioid Induced Side Effects Treatment in Global Market
Table 5. Top Opioid Induced Side Effects Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Opioid Induced Side Effects Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Opioid Induced Side Effects Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Opioid Induced Side Effects Treatment Product Type
Table 9. List of Global Tier 1 Opioid Induced Side Effects Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Induced Side Effects Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Opioid Induced Side Effects Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Opioid Induced Side Effects Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Opioid Induced Side Effects Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Opioid Induced Side Effects Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Opioid Induced Side Effects Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Opioid Induced Side Effects Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Shionogi Corporate Summary
Table 31. Shionogi Opioid Induced Side Effects Treatment Product Offerings
Table 32. Shionogi Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Cubist Pharmaceuticals Corporate Summary
Table 34. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Offerings
Table 35. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 36. SLA Pharma Corporate Summary
Table 37. SLA Pharma Opioid Induced Side Effects Treatment Product Offerings
Table 38. SLA Pharma Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Opioid Induced Side Effects Treatment Product Offerings
Table 41. AstraZeneca Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 42. AIKO Biotechnology Corporate Summary
Table 43. AIKO Biotechnology Opioid Induced Side Effects Treatment Product Offerings
Table 44. AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Progenics Pharmaceuticals Corporate Summary
Table 46. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Offerings
Table 47. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Opioid Induced Side Effects Treatment Segment by Type in 2021
Figure 2. Opioid Induced Side Effects Treatment Segment by Application in 2021
Figure 3. Global Opioid Induced Side Effects Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Opioid Induced Side Effects Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opioid Induced Side Effects Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Opioid Induced Side Effects Treatment Revenue in 2021
Figure 8. By Type - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 12. US Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 24. China Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Shionogi Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. SLA Pharma Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Opioid Induced Side Effects Treatment Segment by Type in 2021
Figure 2. Opioid Induced Side Effects Treatment Segment by Application in 2021
Figure 3. Global Opioid Induced Side Effects Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Opioid Induced Side Effects Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opioid Induced Side Effects Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Opioid Induced Side Effects Treatment Revenue in 2021
Figure 8. By Type - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 12. US Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 24. China Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Opioid Induced Side Effects Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Opioid Induced Side Effects Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Shionogi Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. SLA Pharma Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AIKO Biotechnology Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
